臨床研究等提出・公開システム

Date of registration	Dec. 01, 2025
Last modified on	Dec. 01, 2025
Trial ID	jRCT1051250159

Scientific Title	Research on Treatments for Inflammatory Diseases Using Human-Derived Mesenchymal Stem Cell Conditioned Medium
Public Title	Research on treatmens for inflammatory diseases using MSC-CM

Contact for Scientific Queries	Name	Kato Yoichi
	Affiliation	Shin Yokohama Kato Clinic
	Address	Shin Yokohama Station BLDG 8F, 2-6-13 Shin Yokohama, Kohoku Ward, Yokohama 222-0033
	Telephone	+81-90-1725-1005
	E-mail	kato@katoclinic.info
Contact for Public Queries	Name	Kato Yoichi
	Affiliation	Shin Yokohama Kato Clinic
	Address	Shin Yokohama Station BLDG 8F, 2-6-13 Shin Yokohama, Kohoku Ward, Yokohama 222-0033
	Telephone	+81-90-1725-1005
	E-mail	kato@katoclinic.info

Recruitment status	Recruiting

Anticipated date of first enrollment		Dec. 01, 2025
Target sample size		100
Study Type		Observational
Key inclusion & exclusion criteria	Inclusion Criteria	1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Inclusion criteria for patients are as follows: <Inclusion Criteria> Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.
	Exclusion Criteria	Individuals who meet any of the following conditions will be excluded: 1. Individuals who use narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.
	Age Minimum	18age old over
	Age Maximum	No limit
	Gender	Both
Health Condition(s) or Problem(s) Studied		Inflammatory diseases
Health Condition(s) Keyword		inflamation, inflammatory disease
Health Condition(s) Code		D007249
Primary Outcome(s)		- Conditions of the patient - Serum CRP levels as necessary

Primary Sponsor	Shin Yokohama Kato Clinic

Secondary Sponsor

Secondary Sponsor

Name of Certified Review Board	Safety Assessment and Clinical Research in Japan
Address	13-16 Sanjo Minamicho, Ashiya City, Hyogo
Telephone	+81-797-22-5511
E-Mail	info.rinrishinsa@gmail.com
Approval Status	Approval

Plan to share IPD	No

Countries of Recruitment（Except Japan）	nose